Jeremy Ross
Jeremy Ross
Verified email at
Cited by
Cited by
Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma
MS Davids, AW Roberts, JF Seymour, JM Pagel, BS Kahl, WG Wierda, ...
Journal of Clinical Oncology 35 (8), 826-833, 2017
Serine proteases and their homologs in the Drosophila melanogaster genome: an initial analysis of sequence conservation and phylogenetic relationships
J Ross, H Jiang, MR Kanost, Y Wang
Gene 304, 117-131, 2003
Efficacy of venetoclax as targeted therapy for relapsed/refractory t (11; 14) multiple myeloma
S Kumar, JL Kaufman, C Gasparetto, J Mikhael, R Vij, B Pegourie, ...
Blood 130 (22), 2401-2409, 2017
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
P Moreau, A Chanan-Khan, AW Roberts, AB Agarwal, T Facon, S Kumar, ...
Blood 130 (22), 2392-2400, 2017
STAT3: an important regulator of multiple cytokine functions
SM Stepkowski, W Chen, JA Ross, ZS Nagy, RA Kirken
Transplantation 85 (10), 1372-1377, 2008
The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells
JA Ross, ZS Nagy, RA Kirken
Journal of Biological Chemistry 283 (8), 4699-4713, 2008
Searching in Mother Nature for Anti-Cancer Activity: Anti-Proliferative and Pro-Apoptotic Effect Elicited by Green Barley on Leukemia/Lymphoma Cells
E Robles-Escajeda, D Lerma, AM Nyakeriga, JA Ross, RA Kirken, ...
PloS one 8 (9), e73508, 2013
Regulation of T cell homeostasis by JAKs and STATs
JA Ross, ZS Nagy, H Cheng, SM Stepkowski, RA Kirken
Archivum immunologiae et therapiae experimentalis 55 (4), 231-245, 2007
Phosphoproteomic analysis of the human pathogen Trypanosoma cruzi at the epimastigote stage
ES Nakayasu, MR Gaynor, TJP Sobreira, JA Ross, IC Almeida
Proteomics 9 (13), 3489-3506, 2009
Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary …
A Mitra, JA Ross, G Rodriguez, ZS Nagy, HL Wilson, RA Kirken
Journal of Biological Chemistry 287 (20), 16596-16608, 2012
Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study
S Kumar, R Vij, JL Kaufman, J Mikhael, T Facon, B Pegourie, ...
Blood 128 (22), 488-488, 2016
Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation
JA Ross, H Cheng, ZS Nagy, JA Frost, RA Kirken
Journal of Biological Chemistry 285 (6), 3582-3591, 2010
STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells
ZS Nagy, MJ LeBaron, JA Ross, A Mitra, H Rui, RA Kirken
Mol Cancer 8, 67, 2009
Complement inactivating proteins and intraspecies venom variation in Crotalus oreganus helleri
JD Jurado, ED Rael, CS Lieb, E Nakayasu, WK Hayes, SP Bush, JA Ross
Toxicon 49 (3), 339-350, 2007
Expression and in vitro activation of Manduca sexta prophenoloxidase-activating proteinase-2 precursor (proPAP-2) from baculovirus-infected insect cells
C Ji, Y Wang, J Ross, H Jiang
Protein expression and purification 29 (2), 235-243, 2003
Forskolin-inducible cAMP Pathway Negatively Regulates T-cell Proliferation by Uncoupling the Interleukin-2 Receptor Complex
G Rodriguez, JA Ross, ZS Nagy, RA Kirken
Journal of Biological Chemistry 288 (10), 7137-7146, 2013
JBC Papers in Press. Published on January 22, 2013 as Manuscript M112. 408765
G Rodriguez, JA Ross, ZS Nagy, RA Kirken
Forskolin inducible cAMP pathway
ZS Nagy, RA Kirken, G Rodriguez, JA Ross
Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma
P Moreau, AA Chanan-Khan, AW Roberts, AB Agarwal, T Facon, S Kumar, ...
Blood 128 (22), 975-975, 2016
Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity
H Cheng, JA Ross, JA Frost, RA Kirken
Molecular and cellular biology 28 (7), 2271-2282, 2008
The system can't perform the operation now. Try again later.
Articles 1–20